Taken together, these data suggested that CD83 formed a complex with TAK1-TAB1 on the cell membrane to further activate downstream p-ERK1/2-FOXO1-p21-CDK2 and STAT3-DKK1 signaling pathways in ovarian cancer cells. Here, CDK2 is linked to ovarian carcinoma.